<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35400246</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1-2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Occupational lead exposure and survival with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>100</StartPage><EndPage>107</EndPage><MedlinePgn>100-107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2022.2059379</ELocationID><Abstract><AbstractText><i>Objective:</i> Lead exposure has been hypothesized to increase the risk of ALS, but only two studies have examined the association with ALS survival, and with inconsistent results. The use of occupational history to assess lead exposure can avoid reverse causation that may occur in epidemiologic analyses that use biomarkers of lead exposure collected after ALS onset.<i>Methods:</i> We evaluated the relationship of occupational lead exposure to ALS survival among 135 cases from an international ALS cohort that included deep phenotyping, careful follow-up, and questionnaires to quantify participants' occupation history. ALS patients were recruited in 2015-2019. We determined occupational lead exposure using a job-exposure matrix. We estimated hazard ratios (HR) and 95% confidence intervals (CI) for survival using Cox proportional hazard analysis with adjustment for covariates.<i>Results:</i> A total of 135 ALS patients completed the environmental questionnaires, among whom 38 reached a survival endpoint (death or permanent assisted ventilation). The median survival was 48.3 months (25<sup>th</sup>-75<sup>th</sup> percentile, 30.9-74.1). Older patients and those with initial symptom other than limb onset had shorter survival time. There were 36 ALS cases with occupational lead exposure. After adjusting for age, sex, site of onset, smoking, and military service, lead exposure was associated with an HR of 3.26 (95%CI 1.28-8.28). Results with adjustment for subsets of these covariates were similar.<i>Conclusions:</i> These results suggest that lead exposure <i>prior to onset of ALS</i> is associated with shorter survival <i>following onset</i> of ALS, and this association is independent of other prognostic factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Te-Wei</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuu</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooley</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Tian-Shin</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benatar</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4241-5135</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weisskopf</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4513-9834</Identifier><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES000002</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 TS000244</GrantID><Acronym>TS</Acronym><Agency>ATSDR CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2P299V784P</RegistryNumber><NameOfSubstance UI="D007854">Lead</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007854" MajorTopicYN="N">Lead</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="Y">Occupational Exposure</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Occupation</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">lead</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>Disclosure of interest. The authors declare there are no relevant financial or non-financial competing interests to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35400246</ArticleId><ArticleId IdType="mid">NIHMS1799138</ArticleId><ArticleId IdType="pmc">PMC9547984</ArticleId><ArticleId IdType="doi">10.1080/21678421.2022.2059379</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. Journal of neurology, neurosurgery, and psychiatry. 2010;81(4):385&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. Journal of neurology, neurosurgery, and psychiatry. 2010;81(12):1324&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nature reviews Genetics. 2009;10(11):769&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochimica et biophysica acta. 2015;1852(4):679&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZX, Anderson DW, Mantel N, Roman GC. Motor neuron disease on Guam: temporal occurrence, 1941&#x2013;85. Acta Neurol Scand. 1995;92(4):299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">8848935</ArticleId></ArticleIdList></Reference><Reference><Citation>Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chio A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. 2013;14 Suppl 1:33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434707</ArticleId><ArticleId IdType="pubmed">23678878</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila MA, Longstreth WT Jr., McGuire V, Koepsell TD, van Belle G Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;23. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41(2):210&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9029070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Journal of neurology, neurosurgery, and psychiatry. 2017;88(2):99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136332</ArticleId><ArticleId IdType="pubmed">27261500</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J, Andersen PM, Atassi N, David W, Cudkowicz M, et al. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology. 2018;90(7):e565&#x2013;e74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818014</ArticleId><ArticleId IdType="pubmed">29367439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999;24(4):595&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227691</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006;12(3):RA57&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">16501435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidsky TI, Schneider JS. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 2003;126(Pt 1):5&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">12477693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding F, Dokholyan NV. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(50):19696&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2604981</ArticleId><ArticleId IdType="pubmed">19052230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonk WI, Klomp LW. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans. 2008;36(Pt 6):1322&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19021549</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Peters TL, Beard JD, Umbach DM, Keller J, Mariosa D, et al. Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis. American journal of epidemiology. 2017;186(9):1057&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860433</ArticleId><ArticleId IdType="pubmed">29020133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F, Umbach DM, Stallone L, Richards M, Hu H, Sandler DP. Association of lead exposure with survival in amyotrophic lateral sclerosis. Environmental health perspectives. 2008;116(7):943&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2453164</ArticleId><ArticleId IdType="pubmed">18629318</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, Webster TF. Trade-offs of personal vs. more proxy exposure measures in environmental epidemiology. Epidemiology. 2017;28(5):635&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543716</ArticleId><ArticleId IdType="pubmed">28520644</ArticleId></ArticleIdList></Reference><Reference><Citation>CReATe&gt;Home. [Available from: https://www.rarediseasesnetwork.org/cms/create.</Citation></Reference><Reference><Citation>Cocco P, Dosemeci M, Heineman EF. Brain cancer and occupational exposure to lead. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine. 1998;40(11):937&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9830598</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard JD, Engel LS, Richardson DB, Gammon MD, Baird C, Umbach DM, et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival. PloS one. 2017;12(10):e0185751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634564</ArticleId><ArticleId IdType="pubmed">29016608</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015;37:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4325667</ArticleId><ArticleId IdType="pubmed">25365170</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbergeld EK, Sauk J, Somerman M, Todd A, McNeill F, Fowler B, et al. Lead in bone: storage site, exposure source, and target organ. Neurotoxicology. 1993;14(2&#x2013;3):225&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">8247396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>